EMA Withdrawn: Pemetrexed Pfizer (previously Pemetrexed Hospira UK Limited) (pemetrexed ditromethamine) — Pfizer Europe MA EEIG

View source ↗

Summary

The EMA status indicates the pemetrexed product previously marketed by Hospira/Pfizer has been withdrawn. It was indicated for non-small cell lung carcinoma and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• pemetrexed (ditromethamine) Pfizer (pemetrexed ditromethamine)

Snippet

Status: Withdrawn. Therapeutic area: Carcinoma, Non-Small-Cell Lung;Mesothelioma. MAH: Pfizer Europe MA EEIG. Decision date: 21/10/2020